ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105023 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105023; 2) Community: the network communities that were significantly associated with the response to NSC 105023; 3) Molecule: the relationships between components within communities and NSC 105023; 4) MDR: the compounds that were significantly associated with the NSC 105023.

NSC Compound Enrichment Correlation
NSC 657023 Null 0.00206000157707805 0.28274758
NSC 672446 Null 0.00206000157707805 0.3069024
NSC 722308 N4-octadeyl-arabinocytidylyl-(5'.fwdarw.5')-5-fluoro-2'-deoxy uridine 0.00206000157707805 0.32515724
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00206000157707805 0.44946077
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00206000157707805 0.28862116
NSC 755417 Null 0.00206000157707805 0.57090365
NSC 77830 Cycloguanil Pamoate (USAN) 0.00206000157707805 0.55079893
NSC 129185 Melbex 0.00227238673876898 0.43956918
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.00227238673876898 0.27496334
NSC 637994 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[[3-(diethylamino) propyl]amino]-8-hydroxy-, dihydrochloride 0.00227238673876898 0.51795916
Total:121  Current:12    [First] [Prev] [Next] [Last]